{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-031266","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.126992+00:00","generated_at":"2026-05-30T15:05:57.372289+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"GeoVax Labs boosts ATM equity offering capacity from $4.5M to $30M","bullets":["Maximum aggregate offering price under Sales Agreement with A.G.P./Alliance Global Partners increased from $4,486,846 to $30,000,000.","Sales Agreement originally dated September 25, 2024; amendment filed October 15, 2024.","Increase allows up to $30M in common stock sales via at-the-market offering.","Legal opinion on share legality filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-031266","json":"https://secwatch.observer/filing/0001437749-24-031266.json","markdown":"https://secwatch.observer/filing/0001437749-24-031266.md","text":"https://secwatch.observer/filing/0001437749-24-031266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774924031266/0001437749-24-031266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774924031266/govx20241014_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T15:05:57.372289+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}